Postpartum Depression Global Market Report 2024 - Postpartum Depression Market Share And Trends

The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The postpartum depression market size has grown exponentially in recent years. It will grow from $9.17 billion in 2023 to $12.15 billion in 2024 at a compound annual growth rate (CAGR) of 32.5%. The growth in the historic period can be attributed to maternal mental health awareness, research advancements, public health initiatives, increased screenings.

The postpartum depression market size is expected to see exponential growth in the next few years. It will grow to $36.96 billion in 2028 at a compound annual growth rate (CAGR) of 32.1%. The growth in the forecast period can be attributed to telehealth services, pharmacological advancements, maternal mental health legislation, mental health workforce expansion. Major trends in the forecast period include integrated care models, peer support programs, perinatal mental health apps, mental health screening tools.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Market Drivers and Trends:
An increase in postpartum depression cases is expected to propel the growth of the postpartum depression market going forward. Postpartum depression is an exaggerated worry that develops after giving birth. There may be physical symptoms in addition to it. Postnatal depression and postpartum anxiety frequently coexist and in the first year after giving birth, symptoms might start at any time. Postpartum depression is frequently treated with psychotherapy, commonly known as talk therapy or mental health counseling, medication, or a combination of the two, which results in the growth of the market. For Instance, in May 2022, according to UVA Medical Center, a US-based academic medical center with hospitals and specialty clinics, in the US the rates of postpartum depression symptoms steadily increased by 7.7% between December 2020 and March 2021. Further, there was an increase in postpartum depression symptoms in 36 of the 50 U.S. states and the District of Columbia in 2021. Therefore, an increase in postpartum depression cases will drive the postpartum depression market.

Companies operating in the postpartum depression market are working on new product innovations to sustain their position in the market. The limited treatment choices have led to an increasing innovation need for faster-acting therapies and creative care delivery for postpartum depression. For instance, in February 2023, Biogen Inc., a US-based biotechnology company and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) has accepted the filing of an NDA (new drug application) for zuranolone in the management of the major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication that is being tested as a 14-day, once-daily, rapid-acting oral therapy in people with MDD and PPD. Zuranolone, a neuroactive steroid, acts as a positive allosteric modulator of GABA-A receptors, which is a unique method of action. It is supposed to operate in persons with depression by swiftly resetting dysregulated neural networks to help restore brain function. Zuranolone affects brain networks that control mood, arousal, behavior and even cognition.

Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Major Key Players of the Market:
Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

Postpartum Depression Market 2024 Key Insights:
• The Postpartum Depression Market is expected to grow to$36.96 billion in 2028 at a compound annual growth rate (CAGR) of 32.1%.
• Rising Postpartum Depression Cases Fueling Growth In The Postpartum Depression Market
• Companies Innovating In The Postpartum Depression Market With Faster-Acting Therapies And Creative Care Delivery
• North America was the largest region in the postpartum depression market in 2023.

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13024&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.